InnovAge (INNV) Misses Q1 EPS by 4c

InnovAge (NASDAQ: INNV) reported Q1 EPS of ($0.08), $0.04 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $182.5 million versus the consensus estimate of $177.95 million.

For earnings history and earnings-related data on InnovAge (INNV) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Cue Biopharma, Inc. (CUE) Misses Q2 EPS by 2054c
• Laser Photonics Corporation (LASE) Reports Q2 Loss of $0.08